default author photo

Lei Guang

The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology

6565 MD Anderson Blvd, Unit 1052

Houston, TX 77030

United States

SCHOLARLY PAPERS

3

DOWNLOADS

123

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Apatinib Plus Vinorelbine in Second Line Treatment Failure Wildtype Advanced Non-Small Cell Lung Cancer (VICTOR): A Phase II Three-Dimensional Co-Culture Platforms-Guided Prospective Study

Number of pages: 33 Posted: 24 Sep 2019
Xiangyu Zhang, Yi Xiong, Qing Xia, Fang Wu, Lingli Liu, Yuling Zhou, Liang Zeng, Chunhua Zhou, Chen Xia, Wenjuan Jiang, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Rui Guan, Kunyan Li, Jing Wang, Lei Guang, Yongchang Zhang and Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Hepatology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 47 (1,109,210)
Citation 1

Abstract:

Loading...

Three-Dimensional Co-Culture, Apatinib, Vinorelbine, Second Line Treatment Failure, Non-small Cell Lung Cancer, Prospective Study

2.

Keap1 Deficiency Drives Glucose Dependency and Sensitizes Lung Cancer Cells and Tumors to Glut Inhibition

Number of pages: 45 Posted: 16 Feb 2021
Pranavi Koppula, Kellen Olszewski, Yilei Zhang, Xiaoguang Liu, Lei Guang, Molina Das, Bingliang Fang, Masha Poyurovsky and Boyi Gan
The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Kadmon Corporation, LLC, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, he University of Texas MD Anderson Cancer Center - Department of Thoracic and Cardiovascular Surgery, Kadmon Corporation, LLC and The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology
Downloads 38 (1,209,354)

Abstract:

Loading...

KEAP1, glucose dependency, lung cancer, NRF2, SLC7A11, GLUT, cancer therapy

3.

Apatinib Combined with Vinorelbine in Second Line Treatment Failure Non-Driver Mutation Advanced Non-Small Cell Lung Cancer(VICTOR): A Phase 2, Single-Arm, Prospective Study

Number of pages: 24 Posted: 22 May 2019
Xiangyu Zhang, Yi Xiong, Qing Xia, Fang Wu, Lingli Liu, Yuling Zhou, Liang Zeng, Chunhua Zhou, Chen Xia, Wenjuan Jiang, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Rui Guan, Kunyan Li, Jing Wang, Lei Guang, Yongchang Zhang and Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Hepatology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 38 (1,209,354)

Abstract:

Loading...

Apatinib, Vinorelbine, Second Line Treatment Failure, Non-small Cell Lung Cancer, Prospective Study